Related references
Note: Only part of the references are listed.Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
Enchi Liu et al.
NEUROLOGY (2015)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalities
Wagner Zago et al.
Alzheimers & Dementia (2013)
An MRI Rating Scale for Amyloid-Related Imaging Abnormalities with Edema or Effusion
F. Barkhof et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2013)
MR Imaging Features of Amyloid-Related Imaging Abnormalities
J. Barakos et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2013)
Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
Susanne Ostrowitzki et al.
ARCHIVES OF NEUROLOGY (2012)
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling et al.
LANCET NEUROLOGY (2012)
Clearance of Amyloid-β Protein Deposits in Transgenic Mice following Focal Cerebral Ischemia
W. E. Van Nostrand et al.
NEURODEGENERATIVE DISEASES (2012)
Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab
Christopher Carlson et al.
ALZHEIMERS & DEMENTIA (2011)
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Cerebral Amyloid Angiopathy: A Systematic Review
Alessandro Biffi et al.
JOURNAL OF CLINICAL NEUROLOGY (2011)
Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease
P. A. Yates et al.
NEUROLOGY (2011)
Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
Todd E. Golde et al.
NEURON (2011)
A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer Disease
Ronald S. Black et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2010)
Murine models of Alzheimer's disease and their use in developing immunotherapies
Thomas Wisniewski et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2009)
Improving Interrater Agreement About Brain Microbleeds Development of the Brain Observer MicroBleed Scale (BOMBS)
Charlotte Cordonnier et al.
STROKE (2009)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
MRI and CT in the diagnosis of vascular dementia
ECW van Straaten et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Cerebral microbleeds in Alzheimer's disease
H Hanyu et al.
JOURNAL OF NEUROLOGY (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
A new rating scale for age-related white matter changes applicable to MRI and CT
LO Wahlund et al.
STROKE (2001)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
Share Paper
